ATE264102T1 - Nicotin enthaltende pharmazeutische zusammensetzungen mit schneller transmukosaler absorption - Google Patents

Nicotin enthaltende pharmazeutische zusammensetzungen mit schneller transmukosaler absorption

Info

Publication number
ATE264102T1
ATE264102T1 AT99972537T AT99972537T ATE264102T1 AT E264102 T1 ATE264102 T1 AT E264102T1 AT 99972537 T AT99972537 T AT 99972537T AT 99972537 T AT99972537 T AT 99972537T AT E264102 T1 ATE264102 T1 AT E264102T1
Authority
AT
Austria
Prior art keywords
formulations
nicotine
pharmaceutical compositions
compositions containing
containing nicotine
Prior art date
Application number
AT99972537T
Other languages
English (en)
Inventor
Sven Boerje Andersson
Tomas Landh
Stefan Jonn
Stefan Persson
Nils-Olof Lindberg
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Application granted granted Critical
Publication of ATE264102T1 publication Critical patent/ATE264102T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT99972537T 1998-11-23 1999-11-04 Nicotin enthaltende pharmazeutische zusammensetzungen mit schneller transmukosaler absorption ATE264102T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9803986A SE9803986D0 (sv) 1998-11-23 1998-11-23 New compositions
PCT/SE1999/001983 WO2000030641A1 (en) 1998-11-23 1999-11-04 Nicotine-containing pharmaceutical compositions giving a rapid transmucosal absorption

Publications (1)

Publication Number Publication Date
ATE264102T1 true ATE264102T1 (de) 2004-04-15

Family

ID=20413363

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99972537T ATE264102T1 (de) 1998-11-23 1999-11-04 Nicotin enthaltende pharmazeutische zusammensetzungen mit schneller transmukosaler absorption

Country Status (12)

Country Link
US (1) US6676959B1 (de)
EP (1) EP1131071B1 (de)
JP (1) JP2002530335A (de)
AT (1) ATE264102T1 (de)
AU (1) AU1434000A (de)
DE (1) DE69916486T2 (de)
DK (1) DK1131071T3 (de)
ES (1) ES2220149T3 (de)
HK (1) HK1040614B (de)
PT (1) PT1131071E (de)
SE (1) SE9803986D0 (de)
WO (1) WO2000030641A1 (de)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0103210D0 (sv) * 2001-09-27 2001-09-27 Pharmacia Ab New formulations and use thereof
SE0103211D0 (sv) * 2001-09-27 2001-09-27 Pharmacia Ab New formulations and use thereof
US20030087937A1 (en) * 2001-10-15 2003-05-08 Nils-Olof Lindberg Nicotine and cocoa powder compositions
SE0202365D0 (sv) * 2002-08-05 2002-08-05 Pharmacia Ab New formulation and use thereof
DE10251963A1 (de) * 2002-11-08 2004-05-19 Lts Lohmann Therapie-Systeme Ag Transmucosale pharmazeutische Darreichungsform
US9358296B2 (en) * 2003-02-24 2016-06-07 Pharmaceutical Productions Inc. Transmucosal drug delivery system
SE0300830D0 (sv) * 2003-03-26 2003-03-26 Pharmacia Ab New formulations and use thereof
SE0300831D0 (sv) * 2003-03-26 2003-03-26 Pharmacia Ab New formulations and use therof
US8469036B2 (en) 2003-11-07 2013-06-25 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
FR2882656B1 (fr) * 2005-03-07 2007-06-22 Schwartz Laboratoires Robert S Composition antitabagique
US20070134169A1 (en) * 2005-12-11 2007-06-14 Rabinoff Michael D Methods for smoking cessation or alcohol cessation or other addiction cessation
US7946296B2 (en) * 2006-05-26 2011-05-24 Philip Morris Usa Inc. Dissolvable tobacco film strips and method of making the same
PL2450446T3 (pl) * 2006-09-13 2015-10-30 22Nd Century Ltd Llc Zwiększanie poziomów alkaloidów nikotynowych
MX2009005671A (es) * 2006-12-01 2009-06-08 Cima Labs Inc Forma de dosificacion de nicotina transmucosal oral.
WO2008091592A1 (en) 2007-01-22 2008-07-31 Targacept, Inc. Intranasal, buccal, and sublingual administration of metanicotine analogs
JP2010519196A (ja) * 2007-02-15 2010-06-03 ダーマ−ヤング リミテッド 経粘膜送達を高めるための組成物および方法
US8356606B2 (en) 2007-06-01 2013-01-22 Philip Morris Usa Inc. Production of micronized encapsulated tobacco particles for tobacco flavor delivery from an oral pouch
US9167835B2 (en) 2008-12-30 2015-10-27 Philip Morris Usa Inc. Dissolvable films impregnated with encapsulated tobacco, tea, coffee, botanicals, and flavors for oral products
US9167847B2 (en) 2009-03-16 2015-10-27 Philip Morris Usa Inc. Production of coated tobacco particles suitable for usage in a smokeless tobacoo product
CA2796346C (en) 2010-04-14 2018-10-02 Altria Client Services Inc. Preformed smokeless tobacco product
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
US11116237B2 (en) * 2010-08-11 2021-09-14 R.J. Reynolds Tobacco Company Meltable smokeless tobacco composition
US20230255257A1 (en) * 2010-08-11 2023-08-17 R.J. Reynolds Tobacco Company Meltable smokeless tobacco composition
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US9763928B2 (en) * 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US9044035B2 (en) 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
US20140255452A1 (en) 2013-03-11 2014-09-11 Niconovum Usa, Inc. Method and apparatus for differentiating oral pouch products
US10799548B2 (en) 2013-03-15 2020-10-13 Altria Client Services Llc Modifying taste and sensory irritation of smokeless tobacco and non-tobacco products
US11503853B2 (en) 2013-09-09 2022-11-22 R.J. Reynolds Tobacco Company Smokeless tobacco composition incorporating a botanical material
US10357054B2 (en) 2013-10-16 2019-07-23 R.J. Reynolds Tobacco Company Smokeless tobacco pastille
US9375033B2 (en) 2014-02-14 2016-06-28 R.J. Reynolds Tobacco Company Tobacco-containing gel composition
CN113754634A (zh) 2014-05-27 2021-12-07 R.J.雷诺兹烟草公司 烟碱盐、共晶体和盐共晶体络合物
US10881133B2 (en) 2015-04-16 2021-01-05 R.J. Reynolds Tobacco Company Tobacco-derived cellulosic sugar
US10869497B2 (en) 2015-09-08 2020-12-22 R.J. Reynolds Tobacco Company High-pressure cold pasteurization of tobacco material
DK3379952T3 (da) 2015-11-25 2024-01-08 Reynolds Tobacco Co R Nikotinsalte, co-krystaller og salt-co-krystalkomplekser
US10532046B2 (en) 2015-12-03 2020-01-14 Niconovum Usa, Inc. Multi-phase delivery compositions and products incorporating such compositions
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
US10499684B2 (en) 2016-01-28 2019-12-10 R.J. Reynolds Tobacco Company Tobacco-derived flavorants
US11154087B2 (en) 2016-02-02 2021-10-26 R.J. Reynolds Tobacco Company Method for preparing flavorful compounds isolated from black liquor and products incorporating the flavorful compounds
US11091446B2 (en) 2017-03-24 2021-08-17 R.J. Reynolds Tobacco Company Methods of selectively forming substituted pyrazines
PL3681865T3 (pl) 2017-09-05 2026-02-23 R. J. Reynolds Tobacco Company Sole, kokryształy i kompleksy kokryształów soli nikotyny
US20190307082A1 (en) 2018-04-05 2019-10-10 R.J. Reynolds Tobacco Company Oriental tobacco production methods
WO2019239356A1 (en) 2018-06-15 2019-12-19 R. J. Reynolds Tobacco Company Purification of nicotine
WO2021116855A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral compositions and methods of manufacture
WO2021116865A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Agents for oral composition
WO2022189977A1 (en) 2021-03-09 2022-09-15 Nicoventures Trading Limited Oral products and methods of manufacture
US20220354785A1 (en) 2021-04-22 2022-11-10 Nicoventures Trading Limited Oral lozenge products
EP4333650A1 (de) 2021-05-06 2024-03-13 Nicoventures Trading Limited Orale zusammensetzungen und zugehörige verfahren zur verminderung von halsreizungen
CA3233375A1 (en) 2021-09-30 2023-04-06 Michael Zawadzki Oral product with a basic amine and an ion pairing agent
US20230148660A1 (en) 2021-11-15 2023-05-18 Nicoventures Trading Limited Products with enhanced sensory characteristics
US20250241356A1 (en) 2022-06-24 2025-07-31 Michael S. Daniel Oral composition comprising receptor modulator
GB202214803D0 (en) 2022-10-07 2022-11-23 Nicoventures Trading Ltd Oral product
JP2025533129A (ja) 2022-10-07 2025-10-03 ニコベンチャーズ トレーディング リミテッド 経口製品
AU2023357709A1 (en) 2022-10-07 2025-04-17 Nicoventures Trading Limited Oral product
GB202214771D0 (en) 2022-10-07 2022-11-23 Nicoventures Trading Ltd Oral product
AU2023357713A1 (en) 2022-10-07 2025-04-17 Nicoventures Trading Limited Oral product
GB202214775D0 (en) 2022-10-07 2022-11-23 Nicoventures Trading Ltd Oral product
EP4611564A1 (de) 2022-11-01 2025-09-10 Nicoventures Trading Limited Orale zusammensetzung mit verkapseltem ph-einstellungsmittel
GB202216465D0 (en) 2022-11-04 2022-12-21 Nicoventures Trading Ltd Oral product
EP4611557A1 (de) 2022-11-04 2025-09-10 Nicoventures Trading Limited Orales produkt
EP4672985A1 (de) 2023-02-28 2026-01-07 Nicoventures Trading Limited Koffeinhaltiges orales produkt
GB202304445D0 (en) 2023-03-27 2023-05-10 Nicoventures Trading Ltd Oral product
GB202307278D0 (en) 2023-05-16 2023-06-28 Nicoventures Holdings Ltd Oral product
GB202307279D0 (en) 2023-05-16 2023-06-28 Nicoventures Trading Ltd Oral product
EP4543417A1 (de) * 2023-09-12 2025-04-30 Fertin Pharma A/S Im mund zerfallende nikotintablette zur verwendung unter der lippe
EP4585055A1 (de) 2024-01-12 2025-07-16 Nicoventures Trading Limited Orales produkt mit probiotischer komponente
EP4599698A1 (de) 2024-02-07 2025-08-13 Nicoventures Trading Limited Produkte mit sensorischen mitteln
EP4602929A1 (de) 2024-02-19 2025-08-20 Nicoventures Trading Limited Orales produkt mit pulverbeschichtung
EP4623708A1 (de) 2024-03-26 2025-10-01 Nicoventures Trading Limited Süssstoffzusammensetzung für in beutel verpackte orale produkte
EP4623702A1 (de) 2024-03-27 2025-10-01 Nicoventures Trading Limited Orales produkt
EP4631502A1 (de) 2024-04-12 2025-10-15 Nicoventures Trading Limited Verwendung von flavonen wie quercetin zur steigerung der kognitiven funktion und zur verringerung der nervosität
WO2026013602A1 (en) 2024-07-10 2026-01-15 Rai Strategic Holdings, Inc. Oral products

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783207A (en) * 1985-05-01 1998-07-21 University Of Utah Research Foundation Selectively removable nicotine-containing dosage form for use in the transmucosal delivery of nicotine
JPS62175141A (ja) * 1986-01-29 1987-07-31 Kazuo Takatsu 複合チヨコレ−ト
US5017400A (en) * 1988-06-10 1991-05-21 Suomen Xyrofin Oy Non-cariogenic sweetener
US5004601A (en) 1988-10-14 1991-04-02 Zetachron, Inc. Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
US5098730A (en) * 1988-11-14 1992-03-24 Cultor Ltd. Dietetic sweetening composition
US5512306A (en) * 1992-06-19 1996-04-30 Pharmica Ab Smoking substitute
US5549906A (en) * 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
JPH0940564A (ja) * 1995-07-26 1997-02-10 Taiyo Kagaku Co Ltd 悪酔予防改善用組成物
JPH0956333A (ja) * 1995-08-21 1997-03-04 Kozaburo Shiba 機能性梅チョコレート
AU750808B2 (en) * 1997-10-03 2002-07-25 Cary Medical Corporation Compositon for the treatment of nicotine addiction containing a nicotine receptor antagonist and an anti-depressant or anti-anxiety drug

Also Published As

Publication number Publication date
WO2000030641A1 (en) 2000-06-02
EP1131071A1 (de) 2001-09-12
ES2220149T3 (es) 2004-12-01
DE69916486D1 (de) 2004-05-19
EP1131071B1 (de) 2004-04-14
HK1040614B (en) 2004-10-08
AU1434000A (en) 2000-06-13
HK1040614A1 (en) 2002-06-21
PT1131071E (pt) 2004-06-30
SE9803986D0 (sv) 1998-11-23
DK1131071T3 (da) 2004-05-10
DE69916486T2 (de) 2004-08-26
US6676959B1 (en) 2004-01-13
JP2002530335A (ja) 2002-09-17

Similar Documents

Publication Publication Date Title
ATE264102T1 (de) Nicotin enthaltende pharmazeutische zusammensetzungen mit schneller transmukosaler absorption
EE200300033A (et) Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
IS8726A (is) Meðferðarfræðilegar samsetningar þrýstingslækkandi efna og efna sem hamla gegn æðamyndun
MXPA06000381A (es) Composicion de dulce dental antiplaca y que puede ser masticada.
EE05149B1 (et) Biarlkarboksamiidid, meetod nende valmistamiseks, neid sisaldav ravimkoostis ning nende kasutamine ravis
DE602004017127D1 (de) Langandauernde, aromatisierte darreichungsform zur verlängerten freisetzung von aktivstoffen im mund
TW200505498A (en) Sugar-free oral transmucosal solid dosage forms and uses thereof
ATE444738T1 (de) Verbesserte essbare filmformulierungen mit maltodextrin
NO993520D0 (no) Doseringsformer og fremgangsmåte for å bedre erektil dysfunksjon
BR0109672A (pt) Uso de zd6126 ou de um seu sal farmaceuticamente aceitável e um de: um agente antitumoral de plantina e um taxano, composição farmacêutica, produto de combinação, kit, e, método para a produção de um efeito de danificação vascular em um animal de sangue quente
YU19399A (sh) Lokalni anestetik za spoljnu upotrebu
UA37278C2 (uk) Протикашльова фармацевтична композиція для перорального введення
DK1052973T3 (da) Transmucosale formuleringer af levosimendan
IL140588A0 (en) Therapeutic composition based on flavonoids intended to be used in the treatment of tumours by cytotoxic agents
IS6919A (is) Stöðug lyfjablanda sem felur í sér torsemíð afbrigði II
BR0313224A (pt) Composição farmacêutica contendo composto para terapia da disfunção sexual para ser administrada de modo oral que proporciona rápido inìcio de seus efeitos farmacológicos
DE60016567D1 (de) Makrophagenhaltige zusammensetzung mit antiinfektiösen und hematopoietischen eigenschaften sowie deren herstellungsmethode
SE0103210D0 (sv) New formulations and use thereof
DK0519983T3 (da) Anvendelse af ketorolac til behandling af periodontal sygdom
DE69815277D1 (de) Nimelulide enthaltendes pharmazeutisches präparat zur oralen verabreichung
WO2002051404A8 (fr) Compositions orales
RU98101617A (ru) Средство для лечения заболеваний пародонта и травматических повреждений слизистой оболочки полости рта "виспосил"
DE69938347D1 (de) Medikamentöse verabreichung von nikotin in form von kaugummi
TW200611686A (en) Effervescent oral opiate dosage forms and methods of administering opiates
DE50311479D1 (de) Pharmazeutische zusammensetzung, enthaltend oxcarbazepin mit kontrollierter wirkstofffreisetzung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1131071

Country of ref document: EP

REN Ceased due to non-payment of the annual fee